Electrostatics of Pharmaceutical Aerosols for Pulmonary Delivery

Title:Electrostatics of Pharmaceutical Aerosols for Pulmonary Delivery

Volume: 21 Issue: 27

Author(s): Philip Chi Lip Kwok

Affiliation:

Keywords: Electrostatic charge, pharmaceutical aerosol, particle, deposition, inhalation, lungs, dry powder inhaler, metered dose inhaler, nebuliser, spacer.

Abstract: This paper provides a review on key research findings in the rapidly developing area of pharmaceutical aerosol electrostatics. Solids and liquids can become charged without electric fields, the former by contact or friction and the latter by flowing or spraying. Therefore, charged particles and droplets carrying net charges are produced from pharmaceutical inhalers (e.g. dry powder inhalers, metered dose inhalers, and nebulisers) due to the mechanical processes involved in aerosolisation. The charging depends on many physicochemical factors, such as formulation composition, solid state properties, inhaler material and design, and relative humidity. In silico, in vitro, and limited in vivo studies have shown that electrostatic charges may potentially influence particle deposition in the airways. However, the evidence is not yet conclusive. Furthermore, there are currently no regulatory requirements on the characterisation and control of the electrostatic properties of inhaled formulations. Besides the need for further investigations on the relationship between physicochemical factors and charging characteristics of the aerosols, controlled and detailed in vivo studies are also required to confirm whether charges can affect particle deposition in the airways. Since pharmaceutical aerosol electrostatics is a relatively new research area, much remains to be explored. Thus there is certainly potential for development. New findings in the future may contribute to the advancement of pharmaceutical aerosol formulations and respiratory drug delivery.

Cite this article as:

Lip Kwok Chi Philip, Electrostatics of Pharmaceutical Aerosols for Pulmonary Delivery, Current Pharmaceutical Design 2015; 21 (27) . https://dx.doi.org/10.2174/1381612821666150820110407